Showing results (271-280 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|September 1, 1994
Flumazenil effects on growth hormone response to gamma-hydroxybutyric acidG Gerra, R Caccavari, B Fontanesi, et al.International Clinical Psychopharmacology|January 1, 1991
Comparison of performance of healthy volunteers given prazepam alone or combined with ethanol. Relation to drug plasma concentrationsC Girre, M Hirschhorn, L Bertaux, et al.International Clinical Psychopharmacology|March 1, 1994
Serotonin receptors--where are they going?B E LeonardInternational Clinical Psychopharmacology|January 1, 1994
How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placeboG D Tollefson, S L HolmanInternational Clinical Psychopharmacology|January 1, 1994
Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placeboG Hajak, P Clarenbach, W Fischer, et al.International Clinical Psychopharmacology|October 6, 2007
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostilityLeslie Citrome, Constance B Shope, Karen A Nolan, et al.International Clinical Psychopharmacology|August 1, 2006
Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophreniaIra D Glick, Ziv Shkedy, Andreas SchreinerInternational Clinical Psychopharmacology|October 3, 2006
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countriesCorrado Barbui, Michela Nosè, Maria Angela Mazzi, et al.International Clinical Psychopharmacology|October 3, 2006
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled studyStacey Wasserman, Rupa Iyengar, William F Chaplin, et al.International Clinical Psychopharmacology|May 24, 2007
Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidoneMichael Segal, Avi Avital, Andrei Derevenski, et al.Pageof 212